The Villeneuve-la-Garenne plant continues its transformation through the Potent project, which will enable the group to access the production of active pharmaceutical ingredients (APIs) requiring a very high level of containment. Discover the interview of Didier Combis, CDMO sales director through an article dedicated to High Potency APIS in Specialty Chemicals Magazine